Subcutaneous Interval Lengthening of Vedolizumab for Economic Research

Abroad (travel likely)RecruitingPHASE4

Conditions

Inflammatory Bowel Diseases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Amsterdam UMC, Amsterdam, Netherlands
Contact: Study coordinator (Suzanne Anjie, MD) · s.i.anjie@amsterdamumc.nl · +31655592173

Study leads

G.R.A.M. D'Haens, MD PhD
Principal Investigator
Amsterdam UMC

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance

Crohn Disease · Inflammatory Bowel Diseases · Healthy

Abroad (travel likely)Recruiting

Boston, United States

A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies

Ulcerative Colitis · Inflammatory Bowel Diseases

Abroad (travel likely)Recruiting

Nancy, France

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

Inflammatory Bowel Disease · Crohn Disease · Ulcerative Colitis

Abroad (travel likely)Recruiting

Boston, United States

InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease

Inflammatory Disease · Disease Crohn · Bowel Disease

Abroad (travel likely)RecruitingPHASE3

Amsterdam, Netherlands